Tlaleho ea morao-rao ea lefuba ea #WHO e senola 'nete e makatsang: ho ile ha fumanoa batho ba limilione tse 8.2 ba nang le lefuba ka 2023-e leng palo e phahameng ka ho fetisisa ho tloha ha tlhahlobo ea lefats'e e qala ka 1995. Keketseho ena e tsoang ho limilione tse 7.5 ka 2022 e khutlisetsa lefuba joalo ka lefuba.'molai ea ka sehloohong oa mafu a tšoaetsanoang, ho feta COVID-19.
Leha ho le joalo, koluoa e tebileng le ho feta e pupetsa ts'ebetso ena hape:Antimicrobial resistance (AMR). WHO e rera hore ka 2050, AMR e ka kopabatho ba ka bang limilione tse 10 ba phela selemo le selemolefats'eng ka bophara, moo lefuba le hananang le meriana (DR-TB) e leng sesosa se matla . Ka 2019 feela, AMR e bolaile batho ba limilione tse 1.3 ka kotloloho -ho feta HIV/AIDS le malaria li kopane- 'me ke hona joalesesosa sa boraro se bakang lefu lefatšeng ka bophara. Ntle le ho kenella, mafu a eketsehang a tsoang ho AMR a ka fihla39 milione ka 2050, ka tahlehelo ea moruo topping$ 100 libilione.
Ke Hobane'ng ha Tlhahlobo ea Nako e Leng e sa Buisanoe
Kalafo ea lefuba e itšetlehile ka ho lemoha kapele le mekhoa e nepahetseng ea meriana. Leha ho le joalo, tšebeliso e mpe ea lithibela-mafu e potlakisitse lefuba le hanyetsanang le lithethefatsi tse ngata (MDR-TB), le fetolang mafu a phekolehang ho ba tšokelo e bolaeang. Ka mokhoa o tšosang:
Lefuba le hanyetsanang le meriana le baka 1/3 ea batho ba shoang lefatšeng ka bophara ba AMR.
Batho ba tsofetseng ba tobane le ho eketseha ha lefu la AMR(ho fihla ho 80% ho tloha ka 1990 har'a batho ba baholo).
Phetoho ea boemo ba leholimo e kaAMR e mpefalitse ho ata ka 2.4% ka 2050, e amang libaka tse nang le meputso e tlase ka tsela e sa lekanyetsoang.
WHO e kopa ka potlako hore ho be le mekhoa e mecha ea tlhahlobo e potlakileng ho loants'a tšebeliso e mpe le ho koala likheo tsa kalafo
Macro & Micro-Test's CE-Certified Triple TB Kit: Precision Tools for the AMR Era
Tharollo ea rona e tsamaisana le leano la WHO la ho boloka AMR ka ho thusaho lemoha ka nako e le 'ngoe tšoaetso ea lefuba + rifampicin (RIF) + isoniazid (INH) ho hanyetsa-e bohlokoa bakeng sa ho thibela DR-TB.
Likarolo tsa Bohlokoa:
Lebelo & Nepahalo: Liphetho ka mor'a lihora tse 2–2.5 ka ho toloka ka mokhoa o itekanetseng (ho hlokahala koetliso e fokolang).
Lipheo tse PharalletsengMofuta oa lefu: IS6110
RIF-ho hanyetsa: rpoB (507~533)
INH-resistance: InhA, AhpC, katG 315
Boikutlo bo Phahameng: E lemoha tse fokolang joalo ka libaktheria tse 10/mL (TB) le 150–200 baktheria/mL bakeng sa matšoao a ho hanyetsa.
WHO-E lumellana: E kopana le litataiso tsa taolo ea DR-TB.
Ho lumellana ho pharaletseng: E sebetsa le mekhoa e meholo ea PCR (mohlala, Bio-Rad CFX96, SLAN-96P/S).
Lebaka Leo Sena se Le Bohlokoa:
Ho tseba ka potlako liphatsa tsa lefutso tsa khanyetso ho thibela tšebeliso e sa sebetseng ea lithibela-mafu, ho fokotsa phetiso,
Bitsa Ketso
Ho kopana ha lefuba hape le AMR ho hloka lisebelisoa tse tsamaisang lebelo ka nepo. Setsi sa rona se koala lekhalo lena-ho netefatsa hore kalafo e qala hantle, lekhetlo la pele.
Ithute haholoanyane:
https://www.mmtest.com/mycobacterium-tuberculosis-nucleic-acid-and-rifampicin%ef%bc%8cisoniazid-resistance-product/
Ikopanye:marketing@mmtest.com
#IVD #PCR #AMRCrisis #DrugResistance #TB #ENDTB #MDRTB #Diagnostics #GlobalHealth #WHO #MacroMicroTest
Nako ea poso: Nov-25-2025